Weekly Carboplatin and Taxotere in Platinum Sensitive Relapsed Ovarian or Tubal or Primary Peritoneal Cancers

计划入组 38 人 · 首次发布于 2005 年 11 月 2 日

Vaccine Therapy in Stage II, III, or IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancers

计划入组 13 人 · 首次发布于 2008 年 12 月 5 日

A Study of Carboplatin and DOXIL Plus Bevacizumab in Patients With Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancers

计划入组 54 人 · 首次发布于 2008 年 6 月 17 日

Peritoneal Dialyzate

Rx

Primary sclerosing cholangitis(Engitix )

Werner inhibitor (MSI-high cancers/sensitive cancers)

PRIMARY PHARMACEUTICALS, INC.

United States

PRIMARY HEALTH CARE CORPORATION

Qatar

ASSO DE RECHERCHE CANCERS GYNECOLOGIQUES

France

Nuvectis Pharma's NXP800 Shows Promise in ARID1a-Mutated Ovarian Cancer Trial

NXP800 Receives FDA Orphan Drug Designation for ARID1a-Deficient Ovarian Cancers

Zentalis Pharmaceuticals Restructures to Advance Azenosertib in Gynecological Cancers